Discontinued — last reported Q3 '25

Current Liabilities

Restructuring Reserve

Biogen Restructuring Reserve increased by 144.3% to $320.00M in Q3 2023 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ4 2024
Last reportedQ3 2025

How to read this metric

An increase indicates active cost-cutting or strategic realignment, while a decrease suggests the completion of restructuring phases.

Detailed definition

This represents the estimated liability for costs associated with formal restructuring plans, such as workforce reductio...

Peer comparison

Varies significantly based on the company's current phase of operational transformation.

Metric ID: restructuring_reserve

Historical Data

2 periods
 Q4 '22Q3 '23
Value$131.00M$320.00M
QoQ Change+144.3%
Range$131.00M$320.00M

Restructuring Reserve at Other Companies

Frequently Asked Questions

What is Biogen's restructuring reserve?
Biogen (BIIB) reported restructuring reserve of $320.00M in Q3 2023.
What does restructuring reserve mean?
Funds set aside to cover the costs of reorganizing or downsizing business operations.